The product was developed using STEERLife's FragMelt continuous processing platform, which enables solvent-free manufacturing while maintaining bioequivalence to the reference product.

Bionpharma's etravirine tablet for HIV/AIDS, developed on a continuous manufacturing platform, got Abbreviated New Drug ...

The ​Association for Accessible Medicines, which represents generic drugmakers, is expanding its roster of hired guns.

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

This approval allows Bionpharma to commercialize the product in the United States, expanding patient access to a more ...

Allos AI today announced $5 million in seed financing led by Oxford Science Enterprises (OSE) to commercialize the industry's first "glass-box" Causal AI platform, accelerating the end-to-end ...

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid foundation for ...

The shares of Cipla dropped nearly 2 percent to its day's high on January 13 after the US FDA granted its final approval to ...

With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid foundation for ...

Scientists have uncovered a troubling role for a vitamin A byproduct in cancer, which appears to help tumours slip past the ...

The Republican Study Committee has developed a plan to use the reconciliation process to pass major legislation with 51 ...